Journal of Oncology Pharmacy Practice · 2013 · 19 citations · 10 references
MedicineBiochemistryHematologyClinical BiochemistryHematopathologyPediatric HematologyCoagulation AbnormalitiesPediatric LeukemiasPlasma ProteinsThrombosisEndothelial Dysfunction AssessmentPrognostic Marker AssessmentPrognostic Marker EvaluationVascular Endothelial DysfunctionVon Willebrand Factor Function
BACKGROUND: Acute lymphoblastic leukemia is the most common childhood malignancies, representing nearly one-third of all pediatric cancers. Thrombomodulin is a membrane glycoprotein in the vascular endothelium. Its plasma level depends on the integrity of the endothelium. Soluble thrombomodulin is derived from injured endothelial cells or proteolytically cleaved from thrombomodulin by proteases. Von Willebrand factor is a blood glycoprotein involved in homeostasis. Its plasma level increases in neoplastic diseases and arises from adverse changes in the endothelium. Severe endothelial dysfunction is present during the acute phase of acute lymphoblastic leukemia. Plasma levels of von Willebrand factor and soluble thrombomodulin have been used as indexes of endothelial dysfunction. OBJECTIVE: The aim of this study was to assess serum soluble thrombomodulin and von Willebrand factor levels in children with acute lymphoblastic leukemia during acute phase of the disease to assess their potential prognostic value. PATIENTS AND METHODS: Forty patients with acute lymphoblastic leukemia included 26 males and 14 females with their ages ranged from 2 to 10 years and 20 healthy children of matched age and sex were included in this study. We analyzed serum soluble thrombomodulin and von Willebrand factor levels by enzyme-linked immunosorbent assay. RESULTS: In children with acute lymphoblastic leukemia, there was a significant increase in soluble thrombomodulin, and von Willebrand factor levels during the acute phase of the disease. Children with an unfavorable outcome had higher levels of thrombomodulin and von Willebrand factor levels. CONCLUSIONS: Serum thrombomodulin and von Willebrand factor levels as a parameter of endothelial dysfunction during the acute phase of acute lymphoblastic leukemia might represent an additional prognostic marker in childhood acute lymphoblastic leukemia.
10
Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation
Ching-Hon Pui, Dario Campana, Deqing Pei et al. · New England Journal of Medicine · 2009 · 1.2K citations · Full text
Medicine, Oncology, Pediatrics +12
Stephen P. Hunger, Xiaomin Lu, Meenakshi Devidas et al. · Journal of Clinical Oncology · 2012 · 1.2K citations · Full text
Medicine, Oncology, Pediatrics +7
Anja Möricke, Alfred Reiter, Martin Zimmermann et al. · Blood · 2008 · 610 citations · Full text
Medicine, Oncology, Pediatrics +14
Willem A. Kamps, Henk van den Berg, Eva van den Berg et al. · The Lancet Oncology · 2009 · 248 citations
Medicine, Oncology, Pediatrics +11